Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates

Zinger Key Points
  • Hims & Hers reports quarterly earnings of 1 cent per share which beat the analyst consensus estimate of losses of 3 cents per share.
  • Hims & Hers reports quarterly sales of $246.62 million which beat the analyst consensus estimate of $245.82 million by 0.33%.

Hims & Hers Health, Inc. HIMS reported better-than-expected fourth-quarter financial results after the bell Monday. Here's a look at the highlights.

The Details:

Hims & Hers Health reported quarterly earnings of 1 cent per share which beat the analyst consensus estimate of losses of 3 cents per share.

The company reported quarterly sales of $246.62 million which beat the analyst consensus estimate of $245.82 million by 0.33% and represents a 47.5% increase over sales of $167.2 million from the same period last year.

Hims & Hers said subscribers grew to 1.5 million, up 48% year-over-year in the fourth quarter.

“Our outstanding results in 2023 underscore the power of the Hims & Hers brands and superior execution across the organization,” said Andrew Dudum, CEO of Hims & Hers Health.

“We are continuing to advance our mission to make the world feel great through the power of better health, which is evident in the significant, consistent and category-leading revenue growth and market share gains we have been delivering. In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability through a continued focus on building personalized and accessible treatments in each of our core specialties,” Dudum added.

Outlook: 

Hims & Hers Health sees first-quarter 2024 revenue in the range of $267 million to $272 million, versus the $252.548 million estimate. The company sees fiscal year 2024 revenue of between $1.17 billion and $1.20 billion, versus the $1.099 billion estimate.

Related News: Berkshire Hathaway Report, Shareholder Letter Released: What’s Going On With The Stock?

HIMS Price Action: According to Benzinga Pro, Hims & Hers shares are trading up 16.1% after-hours at $11.90 at the time of publication.

Image: Courtesy of Hims & Hers Health, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsMoverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!